Tekla Healthcare Investors

NYSE:HQH

15.2 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q2
Revenue 5.4645.3054.6645.6284.3153.9563.2163.2653.9125.0213.8913.713.7892.9952.7982.8212.472.3312.7241.6071.1690.975
Cost of Revenue 0000000000000000000000
Gross Profit 5.4645.3054.6645.6284.3153.9563.2163.2653.9125.0213.8913.713.7892.9952.7982.8212.472.3312.7241.6071.1690.975
Gross Profit Ratio 1111111111111111111111
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 5.6155.3185.6865.7915.7486.1936.5516.165.6855.225.155.3235.4585.4475.5995.1845.2895.7966.4335.7494.9264.375
Selling & Marketing Expenses 0.0380.01900000000000000000000
SG&A 5.6535.3365.6865.7915.7486.1936.5516.165.6855.225.155.3235.4585.4475.5995.1845.2895.7966.4335.7494.9264.375
Other Expenses 0000000000000000000000
Operating Expenses 5.6535.3365.6865.7915.7486.1936.5516.165.6855.225.155.3235.4585.4475.5995.1845.2895.7966.4335.7494.9264.375
Operating Income -0.189-0.031-1.022-0.163-1.433-2.237-3.335-2.895-1.773-0.198-1.259-1.613-1.668-2.452-2.801-2.364-2.819-3.465-3.709-4.142-3.757-3.4
Operating Income Ratio -0.035-0.006-0.219-0.029-0.332-0.566-1.037-0.887-0.453-0.04-0.324-0.435-0.44-0.819-1.001-0.838-1.141-1.486-1.362-2.576-3.214-3.487
Total Other Income Expenses Net 85.43899.729-25.80683.326-77.748-112.81169.94291.464194.94748.229-59.641-82.782136.381-63.05788.37938.06865.301-115.037-105.257209.273132.51296.662
Income Before Tax 85.24999.697-26.82883.163-79.181-115.04866.60788.569193.17448.031-60.901-84.394134.713-65.50985.57835.70562.482-118.501-108.966205.132128.75693.261
Income Before Tax Ratio 15.60218.792-5.75214.777-18.35-29.08420.71427.12949.389.566-15.653-22.74635.552-21.87630.58112.65825.292-50.837-40.001127.609110.13795.651
Income Tax Expense 0000000000000000000000
Net Income 85.24999.697-26.82883.163-79.181-115.04866.60788.569193.17448.031-60.901-84.394134.713-65.50985.57835.70562.482-118.501-108.966205.132128.75693.261
Net Income Ratio 15.60218.792-5.75214.777-18.35-29.08420.71427.12949.389.566-15.653-22.74635.552-21.87630.58112.65825.292-50.837-40.001127.609110.13795.651
EPS 1.591.97-0.531.72-1.64-2.481.441.984.331.11-1.41-1.993.14-1.582.060.91.57-3.1-2.865.622.973.3
EPS Diluted 1.591.97-0.531.72-1.64-2.481.441.984.331.11-1.41-1.993.14-1.582.060.91.57-3.1-2.865.622.973.3
EBITDA 0000000000000000000000
EBITDA Ratio 0000000000000000000000